Search
Close this search box.
Search
Close this search box.
Search
Close this search box.

Dame Sue Hill

Professor Dame Sue Hill, DBE, FMedSci, FRSB, FRCP (Hon), FRCPath (Hon) Board of Directors, GGMC Executive Team, G2MC Chief Scientific Officer for England Professor Dame Sue Hill OBE DBE FMedSci FRSB FRCP (Hon) FRCPath (Hon) is the Chief Scientific Officer (CSO) for England and Head of Profession for Healthcare Science. She is a State Registered … Read more

Teji Rakhra-Burris

Teji Rakhra-Burris President & CEO, GGMC Research Program Leader, Sr, Center for Applied Genomics & Precision Medicine, Duke University Medical Center Co-Founder, MeTree&You, Inc. Ms. Rakhra-Burris has a Bachelors of Science in Business Administration from the University of Vermont and a Masters of Art in Molecular Genetics from Washington University in St. Louis. She has … Read more

Grant Wood

Grant Wood CEO, GGMC Steering Committee, G2MC Technology Executive in Clinical Genomics, USA Grant Wood has 17 years experience with a major US healthcare system, designing and leading development of computer systems that support healthcare providers and researchers in advancing and delivering genomic-based clinical care. He has a breadth of knowledge in all aspects of … Read more

Scott Sundseth

Scott Sundseth, Ph.D. Advisory Board Member, GGMC Program Director, IHCC Founder, Sundseth Consulting, LLC Sundseth has applied pharmacogenomic analysis to drug discovery and development across multiple therapeutic areas and for diverse healthcare enterprises for over 30 years. As Founder of Sundseth Consulting and Chief Scientific Officer at Cabernet Pharmaceuticals, Sundseth has advised clients on how … Read more

Geoff Ginsburg

Geoff Ginsburg, M.D., Ph.D. Advisory Board Member, GGMC Co-Chair, IHCC Chief Medical and Scientific Officer, All of Us Research Program, National Institutes of Health Professor of Medicine, Pathology and Biomedical Engineering, Duke University, USA Geoffrey Ginsburg, M.D., Ph.D., is the Chief Medical and Scientific Officer of the All of Us Research Program at the National … Read more

Gabriela Repetto

Gabriela Repetto, M.D. Board of Directors, GGMC Co-Chair, G2MC Professor of Genetics, Facultad de Medicina, Clinica Alemana Universidad del Desarrollo, Santiago, Chile Dr. Repetto is a Clinical Geneticist and Director of the Center for Genetics and Genomics at Facultad de Medicina Clinica Alemana Universidad del Desarrollo in Santiago, Chile, a leading clinical, teaching and research … Read more

Catalina Lopez-Correa

Catalina Lopez-Correa, M.D., Ph.D. Board of Directors, GGMC Co-Chair, G2MC Executive Director, Genome Canada Dr. Lopez-Correa is Executive Director of the Canadian COVID19 Genomics Network (CanCOGen) with Genome Canada. In this capacity, she is coordinating efforts across Canada to sequence human and viral genomes and use the data to help shape policy and public health … Read more

George P. Patrinos

George P. Patrinos, Ph.D. Secretary, GGMC Chair, G2MC Professor of Pharmacogenomics, University of Patras School of Health Sciences, Department of Pharmacy, Greece Adjunct Full Professor, United Arab Emirates University, College of Medicine and Health Sciences, Department of Genetics and Genomics, UAE Dr. Patrinos group is internationally renowned for his involvement in the field of pharmacogenomics … Read more

Peter Goodhand

Peter Goodhand Co-Chair, IHCC Development Committee, GGMC CEO, Global Alliance for Genomics and Health (GA4GH) Peter Goodhand is a leader in the global health sector, holding senior executive and board member positions in the health research advancement community.  He played a key role in the creation of the Global Alliance for Genomics and Health (GA4GH) … Read more

Alan Shuldiner

Alan Shuldiner, M.D. Vice-Chair, GGMC Executive Team, G2MC Vice President, Regeneron Genetics Center, Regeneron Pharmaceuticals, Inc., USA John Whitehurst Professor of Medicine, University of Maryland School of Medicine, USA Dr. Shuldiner founded and directs the Discovery Research Investigating Founder Population Traits (DRIFT) Program at the Regeneron Genetics Center. Their goals are to (i) catalogue population-specific … Read more